Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells

Li Li, Joseph M. Miano, Brian Mercer, Eric N. Olson

Research output: Contribution to journalArticle

273 Scopus citations

Abstract

SM22a is a putative calcium-binding protein that is expressed in cardiac, smooth, and skeletal muscle lineages during mouse embryogenesis and in adult smooth muscle cells (SMC). To define the mechanisms that regulate smooth muscle-specific gene transcription, we isolated the SM22α gene and analyzed its 5'-flanking region for elements that direct smooth muscle expression in transgenic mice. Using a series of promoter deletions, a region of the SM22α promoter containing 445 base pairs of 5'-flanking sequence was found to be sufficient to direct the specific expression of a lacZ transgene in mouse embryos in the vascular smooth, cardiac, and skeletal muscle lineages in a temporospatial pattern similar to that of the endogenous SM22α gene. However, in contrast to the endogenous gene, transgene expression was not detected in venous, nor visceral SMCs. This SM22α-lacZ transgene was therefore able to distinguish between the transcriptional regulatory programs that control gene expression in vascular and visceral SMCs and revealed heretofore unrecognized differences between these SMC types. These results suggest that distinct transcriptional regulatory programs control muscle gene expression in vascular and visceral SMCs.

Original languageEnglish (US)
Pages (from-to)849-859
Number of pages11
JournalJournal of Cell Biology
Volume132
Issue number5
DOIs
StatePublished - Mar 1 1996

    Fingerprint

ASJC Scopus subject areas

  • Cell Biology

Cite this